A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: mistake (35), fault (22), slip (31)

Capecitabine-Radiotherapy

Description
Chemotherapy Protocol PANCREATIC CANCER CAPECITABINE (RADIOTHERAPY) Regimen • Pancreatic Cancer – Capecitabine (Radiotherapy) Indication • Locally advanced, non-metastatic pancreatic cancer • WHO performance status
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Pancreas/Capecitabine-Radiotherapy.pdf

Capecitabine-Mitomycin

Description
Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE-MITOMYCIN Regimen • Colorectal Cancer – Capecitabine-Mitomycin Indication • Second / third line therapy of metastatic/advanced colorectal cancer
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Mitomycin.pdf

Capecitabine-Mitomycin-Radiotherpy

Description
Chemotherapy Protocol ANAL CANCER CAPECITABINE-MITOMYCIN-RADIOTHERAPY Regimen • Anal Cancer – Capecitabine-Mitomycin-Radiotherapy Indication • Squamous cell carcinoma of the anus • WHO
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Mitomycin-Radiotherpy.pdf

Capecitabine (21 day)

Description
Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE (21 day) Regimen • Colorectal Cancer – Capecitabine (21 day) Indication • Metastatic / advanced colorectal cancer • Adjuvant therapy of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine21day.pdf

Capecitabine (14 day)

Description
Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE (14 day) Regimen • Colorectal Cancer – Capecitabine (14 day) Indication • Metastatic / advanced colorectal cancer • Adjuvant therapy of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine14day.pdf

Neuroendocrine-Sunitinib Ver 1

Description
Chemotherapy Protocol NEUROENDOCRINE SUNITINIB Regimen Neuroendocrine - Sunitinib Indication The 1st, 2nd or 3rd line treatment of pancreatic neuroendocrine carcinomas that are
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Neuroendocrine-Sunitinib-Ver-1.pdf

Neuroendocrine-Cisplatin-Fluorouracil-Streptozocin

Description
Chemotherapy Protocol NEUROENDOCRINE CISPLATIN-FLUOROURACIL-FOLINIC ACID-STREPTOZOCIN (FCiSt) Regimen • Neuroendocrine – Cisplatin-Fluorouracil-Folinic Acid-Streptozocin (FCiST) Indication • Metastatic or locally
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Neuroendocrine-Cisplatin-Fluorouracil-Streptozocin.pdf

Temozolomide RT (7 day)

Description
Chemotherapy Protocol Central Nervous System TEMOZOLOMIDE RT (7 day) Regimen • CNS – Temozolomide RT (7 day) Indication • First line treatment of newly
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Temozolomide-RT-7-day.pdf

Temozolomide (150)

Description
Chemotherapy Protocol Central Nervous System TEMOZOLOMIDE (150) Regimen • CNS – Temozolomide (150) Indication • First line treatment of newly diagnosed glioblastoma multiforma starting
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Temozolomide-150.pdf

Anastrozole-Palbociclib

Description
Chemotherapy Protocol Breast Cancer Anastrozole-Palbociclib Regimen • Breast Cancer – Anastrozole-Palbociclib Indication • Palbociclib in combination with an aromatase inhibitor is indicated
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Anastrozole-Palbociclib.pdf
231 to 240 of 630
Previous … 22 23 24 25 26 … Next